as of 11-09-2026 11:18am EST
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | PROVO |
| Market Cap: | 242.4M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 445.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | -5.13 | EPS Growth: | 207.80 |
| 52 Week Low/High: | $4.10 - $11.67 | Next Earning Date: | 11-05-2026 |
| Revenue: | $3,176,718,000 | Revenue Growth: | 48.98% |
| Revenue Growth (this year): | -14.11% | Revenue Growth (next year): | 10.10% |
| P/E Ratio: | -0.80 | Index: | |
| Free Cash Flow: | 46.0M | FCF Growth: | N/A |
SEC 8-K filings with transcript text
Nov 5, 2026 · 99% conf.
1D
+6.14%
$5.30
Act: -8.56%
5D
+12.80%
$5.63
20D
+11.95%
$5.59
2 ef20085001_ex99-1.htm
Exhibit 99.1
Nu Skin Enterprises Reports Third Quarter Earnings
PROVO, Utah — Nov. 5, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within its guidance range.
Executive Summary
Q3 2026 vs. Prior-year Quarter
Revenue
$311.0 million; (14.6)%
• (1.1)%
FX impact or $(3.9) million
Earnings Per Share (EPS)
$(0.02) or $0.10 excluding certain charges compared to $0.34
Customers
609,469; (18)%
Paid Affiliates
116,449; (10)%
Sales Leaders
26,995; (13)%
“Third quarter revenue came in within our guidance range as we continued executing on our strategic priorities amid a challenging operating environment,” said Ryan Napierski, Nu Skin president and CEO. “During the quarter, we held our Nu Skin LIVE global convention in Japan, where we were excited to gather with 12,000 of our sales leaders and preview our next anti-aging offerings focused on women’s health. We continue to see adoption of our Prysm iO platform, including year-to-date growth in revenue from our flagship LifePak nutritional supplements. Looking ahead, we are focused on driving affiliate and customer engagement through the holiday season and anticipate sequential growth in the fourth quarter.”
Nu Skin Enterprises Reports Third Quarter 2026 Financial Results
page 2
Q3 2026 Year-over-year Operating Results
Revenue
$311.0 million compared to $364.2 million
• (1.1)%
FX impact or $(3.9) million
Gross Margin
65.0% compared to 70.5%
• Nu
Skin business was 76.6% compared to 77.7%
Selling Expenses
33.2% compared to 35.8%
• Nu
Skin business was 40.9% compared to 41.7%
G&A Expenses
30.2% compared to 28.8%
Operating Margin
1.6% or 3.7% excluding certain charges compared to 5.9%
Interest Expense
$3.5 million compared to $4.1 million
Other Income/ (Expense)
$0.3 million compared to $(1.5) million
Income Tax Rate
139.3% or 42.7% excluding certain charges compared to (6.8)%
EPS
$(0.02) or $0.10 excluding certain charges compared to $0.34
Stockholder Value
Dividend Payments
$2.9 million
Stock Repurchases
$0.0 million
• $137.3
million remaining in authorization
Q4 and Full-year 2026 Outlook
Q4 2026 Revenue
$310 to $340 million; (16)% to (8)%
• Approximately
1% FX impact
$0.05 to $0.15 or $0.11 to $0.21 on an adjusted basis
2026 Revenue
$1.26 to $1.29 billion; (15)% to (13)%
• Approximately
(1)% FX impact
$(5.08) to $(4.98) or $0.55 to $0.65 on an adjusted basis
“For 2026, we project revenue of $1.26 billion to $1.29 billion and earnings per share of $(5.08) to $(4.98) with adjusted EPS of $0.55 to $0.65,” said Chelsea Lantz, interim chief financial officer. “For the fourth quarter, we project revenue between $310 million and $340 million, with earnings per share in the range of $0.05 to $0.15 or $0.11 to $0.21 on an adjusted basis.”
Nu Skin Enterprises Reports Third Quarter 2026 Financial Results
page 3
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through Nov. 19, 2026.
About Nu Skin Enterprises Inc.
The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.
Nu Skin Enterprises Reports Third Quarter 2026 Financial Results
page 4
Important Information Regarding
represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, and affiliates and customers; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency flu
Aug 10, 2026 · 99% conf.
1D
+6.12%
$5.48
Act: -5.72%
5D
+12.76%
$5.82
20D
+11.91%
$5.77
2 ef20079831_ex99-1.htm
Exhibit 99.1
Nu Skin Enterprises Reports Second Quarter Results
PROVO, Utah — Aug. 10, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results.
Executive Summary
Q2 2026 vs. Prior-year Quarter
Revenue
$320.1 million; (17.1)%
• (1.0)% FX impact or $(4.0) million
Earnings Per Share (EPS)
$(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43
Customers
660,037; (14)%
Paid Affiliates
120,291; (8)%
Sales Leaders
26,998; (9)%
“We continue to make progress toward our long-term strategy with the continued rollout of Prysm iO and preparations for the formal launch of India,” said Ryan Napierski, Nu Skin president and CEO. “As these initiatives are taking hold, we are incorporating valuable learnings to strengthen our plans moving forward. At the same time, we are re-aligning our organizational resources to better position the business to drive sustainable, long-term value for our shareholders.”
Nu Skin Enterprises Reports Second Quarter 2026 Financial Results
page 2
Q2 2026 Year-over-year Operating Results
Revenue
$320.1 million compared to $386.1 million
• (1.0)% FX impact or $(4.0) million
Gross Margin
68.2% compared to 68.8%
• Nu Skin business was 77.7% compared to 77.5%
Selling Expenses
33.7% compared to 33.2%
• Nu Skin business was 39.8% compared to 40.0%
G&A Expenses
28.4% compared to 27.6%
Operating Margin
(18.5)% or 6.1% excluding non-cash impairment charge compared to 8.0%
Interest Expense
$3.3 million compared to $2.5 million
Other Income (Expense)
$(0.5) million compared to $(0.8) million
Income Tax Rate
(295.4)% or 36.6% excluding non-cash tax charge compared to 23.0%
EPS
$(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43
Stockholder Value
Dividend Payments
$2.9 million
Stock Repurchases
$0.0 million
• $137.3 million remaining in authorization
Q3 and Full-year 2026 Outlook
Q3 2026 Revenue
$310 to $340 million; (15)% to (7)%
• Approximately (3) to (2)% FX impact
$0.00 to $0.09 or $0.10 to $0.20 on an adjusted basis
2026 Revenue
$1.28 to $1.35 billion; (14)% to (9)%
• Approximately (1)% FX impact
($4.90) to ($4.73) or $0.70 to $0.90 on an adjusted basis
“We delivered adjusted earnings per share near the midpoint of our guidance, reflecting our ongoing focus on profitability and disciplined execution,” said Chelsea Lantz, interim chief financial officer. “Based on our first-half performance and outlook for the rest of the year, we are updating our annual guidance to revenue of $1.28 billion to $1.35 billion and adjusted earnings per share of $0.70 to $0.90. For the third quarter, we expect revenue between $310 million and $340 million, with adjusted earnings per share in the range of $0.10 to $0.20.”
Nu Skin Enterprises Reports Second Quarter 2026 Financial Results
page 3
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through Aug. 24, 2026.
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, initiatives, shareholder value, Prysm launch and its timing, and India expansion; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency fluctuations, uses of cash, financial p
May 7, 2026 · 100% conf.
1D
-6.34%
$6.57
Act: +0.71%
5D
-6.90%
$6.54
Act: -10.54%
20D
-10.15%
$6.31
Act: -23.50%
2 ef20072663_ex99-1.htm
Exhibit 99.1
Nu Skin Enterprises Reports First Quarter Results
PROVO, Utah — May 7, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range.
Executive Summary
Q1 2026 vs. Prior-year Quarter
Revenue
$320.6 million; (12.0)%
• +1.1% FX impact or $3.9 million
Earnings Per Share (EPS)
$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges
Customers
669,535; (14)%
Paid Affiliates
120,850; (8)%
Sales Leaders
26,915; (13)%
“We delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment,” said Ryan Napierski, Nu Skin president and CEO. “As we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO™, ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders.
“We are encouraged by early signs of improving paid affiliates and new sales leader development in several markets as our leaders begin integrating Prysm iO into their businesses and continue to build upon our leading anti-aging Tru Face® brand. We are focused on partnering with our sales force on leveraging the proprietary nutritional health biomarker tracking from Prysm iO to expand the channel as we prepare to drive customer subscriptions for our wellness products. While these initiatives will take time to develop, we remain confident that they will increase sales leader engagement and expand our global reach over time to drive the next phase of growth for Nu Skin.”
Nu Skin Enterprises Reports First Quarter 2026 Financial Results
page 2
Q1 2026 Year-over-year Operating Results
Revenue
$320.6 million compared to $364.5 million
• +1.1% FX impact or $3.9 million
Gross Margin
66.9% or 67.9% excluding certain charges compared to 67.8%
• Nu Skin business was 76.9% compared to 76.7%
Selling Expenses
34.3% compared to 32.5%
• Nu Skin business was 40.5% compared to 38.7%
G&A Expenses
30.7% or 29.9% excluding certain charges compared to 31.1% or 28.9% excluding certain charges
Impairment Expenses
$1.8 million impairment compared to $25.1 million impairment
Operating Margin
1.3% or 3.6% excluding certain charges compared to (2.7)% or 6.4% excluding impairment and other charges
Interest Expense
$4.3 million compared to $3.3 million
Other Income (Expense)
$2.8 million compared to $(28.4) million
• Prior year reflects $28.1 million unrealized loss on investment
Income Tax Rate
29.4% compared to 20.1%
EPS
$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges
Stockholder Value
Dividend Payments
$2.9 million
Stock Repurchases
$5.0 million
• $137.3 million remaining in authorization
Q2 and Full-year 2026 Outlook
Q2 2026 Revenue
$330 to $360 million; (15)% to (7)%
• Approximately 0% FX impact
$0.15 to $0.25
2026 Revenue
$1.35 to $1.50 billion; (9)% to 1%
• Approximately (1)% FX impact
$0.70 to $1.10 or $0.80 to $1.20 excluding certain charges
“In addition to delivering on revenue and adjusted earnings, we returned $8 million to shareholders in the form of dividends and share repurchases,” said Chelsea Lantz, interim chief financial officer. “We were also able to refinance our debt, extending our liquidity as we invest in growth initiatives and navigate market volatility while executing on our strategy. We are maintaining our annual guidance for 2026 on an adjusted basis. For the second quarter, we project revenue between $330 million and $360 million, with earnings per share in the range of $0.15 to $0.25.”
Nu Skin Enterprises Reports First Quarter 2026 Financial Results
page 3
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com. A replay of the webcast will be available on the same page through May 21, 2026.
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellnes
See how NUS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.